Opinion

Video

Hepatic Artery Infusion Data in Unresectable Colorectal Cancer Liver Metastases

Author(s):

Ryan Merkow, MD, MS,Louise Catherine Connell, MB BCh BAO, BMedSc

A surgical oncologist and gastrointestinal oncologist review data on hepatic artery infusion therapy in unresectable colorectal cancer liver metastases.

Related Videos
2 experts in this video
2 experts in this video
2 expert is featured in this series.
2 expert is featured in this series.
2 experts in this video
2 experts in this video
Related Content
Sheela Rao, MBBS, MD, FRCP
January 7th 2025

Retifanlimab Emerges as Potential New SOC in Advanced SCAC

James J. Harding, MD, director, Early Drug Development, Memorial Sloan Kettering Cancer Center
December 30th 2024

FDA Approval Insights: Zanidatamab in Pretreated, HER2+ Biliary Tract Cancer

Aparna Parikh, MD
January 5th 2025

Patient Factors Drive IO Combination Selection in Unresectable HCC

OncLive On Air
September 11th 2024

Oncology Experts Preview Top Abstracts From the 2024 ESMO Congress

Satri-Cel in CLDN18.2+ Advanced Gastric/GEJ Cancer | Image Credit: © Sebastian Kaulitzki – stock.adobe.com
January 3rd 2025

Satri-Cel Improves PFS in Pretreated CLDN18.2+ Advanced Gastric/GEJ Cancer

Alison Schram, MD, assistant attending physician, Memorial Sloan Kettering Cancer Center
January 2nd 2025

FDA Approval Insights: Zenocutuzumab for NRG1+ Pancreatic Adenocarcinoma and NSCLC: With Alison Schram, MD